- Home
- FYBR vs RGC Comparison
FYBR vs RGC Comparison
Compare FYBR & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FYBR | RGC |
|---|---|---|
| Founded | 1935 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.8B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FYBR | RGC |
|---|---|---|
| Price | $38.21 | $51.17 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 412.8K |
| Earning Date | 02-19-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,106,000,000.00 | N/A |
| Revenue This Year | $5.86 | N/A |
| Revenue Next Year | $3.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.25 | N/A |
| 52 Week Low | $35.01 | $0.09 |
| 52 Week High | $38.31 | $83.60 |
Technical Indicators
Market Signals| Indicator | FYBR | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 62.55 | 86.96 |
| Support Level | $38.06 | $20.70 |
| Resistance Level | $38.30 | $25.50 |
| Average True Range (ATR) | 0.10 | 4.69 |
| MACD | -0.01 | 2.31 |
| Stochastic Oscillator | 66.67 | 98.07 |
Price Performance
Historical ComparisonAbout FYBR Frontier Communications Parent Inc.
Frontier Communications Parent Inc is a communications and technology provider offering broadband services. The company provides voice services, including data-based voice over Internet protocol (VoIP) and unified communications as a service (UCaaS), as well as long-distance and voice messaging services, to consumer and business customers in all its markets.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.